Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by robs View PostDo you mind posting the current status of the article? This thread is still viewed by other people and we didn't post updates for the last days. Thanks!
The MS is under unofficial review by 3 David's friends. 2 of them are clinical scientists / clinician.
For anyone interested, please take a look here
http://dl.dropbox.com/u/4125508/SEQa...11229.2.OR.pdfMarco
Comment
-
Sorry for the delay, the manuscript has been email to everyone. Perhaps someone (Marco?) can take the lead integrating comments/suggestions back into GDoc so we can continue to revise. I think the key things we need to do are:
1. Remove citations to websites. In most cases the citation was not necessary anyways and if it really is, we should find a peer-review citation.
2. Mention the 30+ papers that cited SEQanswers right way in the abstract.
3. Focus on the community. Its size and the members, of which many are key developers of software and methods for analyzing HTS data.
There are some word usage issues and a need to formalize the tone a bit, but I think we should be done soon. I would be in favor of writing the clearest and most concise abstract possible (~100 words). I will work on this today.
Comment
-
Originally posted by genericforms View PostSorry for the delay, the manuscript has been email to everyone. Perhaps someone (Marco?) can take the lead integrating comments/suggestions back into GDoc so we can continue to revise. I think the key things we need to do are:
1. Remove citations to websites. In most cases the citation was not necessary anyways and if it really is, we should find a peer-review citation.
2. Mention the 30+ papers that cited SEQanswers right way in the abstract.
3. Focus on the community. Its size and the members, of which many are key developers of software and methods for analyzing HTS data.
There are some word usage issues and a need to formalize the tone a bit, but I think we should be done soon. I would be in favor of writing the clearest and most concise abstract possible (~100 words). I will work on this today.Marco
Comment
-
Job forum tag cloud
Originally posted by Joann View PostHow about also posting your poster here for us when it is complete and you have presented it? I am sure we are an interested audience.
Comment
-
SEQanswers published!
Published online Mar. 13, 2012
Comment
Latest Articles
Collapse
-
by seqadmin
Next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR) are essential techniques for investigating the genome, transcriptome, and epigenome. In many cases, choosing the appropriate technique is straightforward, but in others, it can be more challenging to determine the most effective option. A simple distinction is that smaller, more focused projects are typically better suited for qPCR, while larger, more complex datasets benefit from NGS. However,...-
Channel: Articles
10-18-2024, 07:11 AM -
-
by seqadmin
Non-coding RNAs (ncRNAs) do not code for proteins but play important roles in numerous cellular processes including gene silencing, developmental pathways, and more. There are numerous types including microRNA (miRNA), long ncRNA (lncRNA), circular RNA (circRNA), and more. In this article, we discuss innovative ncRNA research and explore recent technological advancements that improve the study of ncRNAs.
Nobel Prize for MicroRNA Discovery
This week,...-
Channel: Articles
10-07-2024, 08:07 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
New Model Aims to Explain Polygenic Diseases by Connecting Genomic Mutations and Regulatory Networks
by seqadmin
Started by seqadmin, Yesterday, 05:31 AM
|
0 responses
10 views
0 likes
|
Last Post
by seqadmin
Yesterday, 05:31 AM
|
||
Started by seqadmin, 10-24-2024, 06:58 AM
|
0 responses
20 views
0 likes
|
Last Post
by seqadmin
10-24-2024, 06:58 AM
|
||
New AI Model Designs Synthetic DNA Switches for Targeted Gene Expression in Specific Cell Types
by seqadmin
Started by seqadmin, 10-23-2024, 08:43 AM
|
0 responses
48 views
0 likes
|
Last Post
by seqadmin
10-23-2024, 08:43 AM
|
||
Started by seqadmin, 10-17-2024, 07:29 AM
|
0 responses
58 views
0 likes
|
Last Post
by seqadmin
10-17-2024, 07:29 AM
|
Comment